Pricing
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Full screen
Dan Kemp
View all (0)
This company has no teams yet
View all
HQ
4 people · 0 jobs
Tango Therapeutics
3 followers
Science
6 followers
Cellares
5 followers
Amgen
302 followers
Revvity
12 followers
Gilead Sciences
172 followers
Regeneron
144 followers
Illumina
81 followers
Agilent Technologies
89 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
49 followers
Explore companies